Executive summary of the stages of reproductive aging workshop + 10: Addressing the unfinished agenda of staging reproductive aging

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 4, 2012, Pages 1159-1168

  Harlow, Siobán D ^a   Gass, Margery ^b   Hall, Janet E ^c   Lobo, Roger ^d   Maki, Pauline ^e   Rebar, Robert W ^f   Sherman, Sherry ^g   Sluss, Patrick M ^c   De Villiers, Tobie J ^h  

^a UNIVERSITY OF MICHIGAN   (United States)

^b North American Menopause Society   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE   (United States)

^g National Institute of Aging   (United States)

^h International Menopause Society   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; INHIBIN B; MUELLERIAN INHIBITING FACTOR;

2001 STAGES OF REPRODUCTIVE AGING WORKSHOP; AGE; AGING; BODY SIZE; CHRONIC DISEASE; CLIMACTERIUM; CLINICAL ASSESSMENT TOOL; CLINICAL DECISION MAKING; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; CRITERION VARIABLE; ENDOCRINE DISEASE; ENDOMETRIUM ABLATION; ETHNICITY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYSTERECTOMY; LIFESTYLE; OVARY POLYCYSTIC DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; REPRODUCTION;

AGED; AGED, 80 AND OVER; AGING; BIOMEDICAL RESEARCH; ENDOCRINE SYSTEM DISEASES; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MENOPAUSE; MIDDLE AGED; OVARY; POSTMENOPAUSE; REPRODUCTION; WOMEN'S HEALTH;

EID: 84859532410     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-3362     Document Type: Conference Paper

References (90)

1. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001;4:267-272. (Pubitemid 34002968)
2. Soules MR, Sherman S, Parrott E, et al. Stages of Reproductive Aging Workshop (STRAW). J Womens Health Gend Based Med 2001;10:843-848. (Pubitemid 33138765)
3. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001;76:874-878. (Pubitemid 33031310)
4. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW) Park City, Utah, July, 2001. Menopause 2001;8:402-407. (Pubitemid 33111575)
5. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303.
6. Bromberger JT, Schott LL, Kravitz HM, et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN). Arch Gen Psychiatry 2010;67:598-607.
7. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351-358.
8. Freeman EW, Grisso JA, Berlin J, Sammel M, Garcia-Espana B, Hollander L. Symptom reports from a cohort of African American and white women in the late reproductive years. Menopause 2001;8:33-42. (Pubitemid 32066578)
9. Hollander LE, Freeman EW, Sammel MD, Berlin JA, Grisso JA, Battistini M. Sleep quality, estradiol levels, and behavioral factors in late reproductive age women. Obstet Gynecol 2001;98:391-397.
10. Lee CG, Carr MC, Murdoch SJ, et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab 2009;94:1104-1110.
11. Maki PM, Freeman EW, Greendale GA, et al. Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition. Menopause 2010;17:815-822.
12. Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol 2009;54:2366-2373.
13. Neer RM. Bone loss across the menopausal transition. Ann N Y Acad Sci 2010;1192:66-71.
14. Sowers MR, Jannausch M, McConnell D, et al. Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab 2006;91:1261-1267.
15. Woods NF, Mitchell ES. Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Sleep 2010;33:539-549.
16. Bastian LA, Smith CM, Nanda K. Is this woman perimenopausal? JAMA 2003;289:895-902. (Pubitemid 37430350)
17. Santoro N, Brockwell S, Johnston J, et al. Helping midlife women predict the onset of the final menses: SWAN, the Study of Women's Health Across the Nation. Menopause 2007;14:415-424.
18. Utian WH. Menopause-related definitions. Int Congress Series 2004;1266:133-138.
19. Harlow SD, Cain K, Crawford S, et al. Evaluation of four proposed bleeding criteria for the onset of late menopausal transition. J Clin Endocrinol Metab 2006;91:3432-3438. (Pubitemid 44402115)
20. Harlow SD, Crawford S, Dennerstein L, Burger HG, Mitchell ES, Sowers MF. Recommendations from a multi-study evaluation of proposed criteria for staging reproductive aging. Climacteric 2007;10:112-119. (Pubitemid 46482175)
21. Harlow SD, Mitchell ES, Crawford S, Nan B, Little R, Taffe J. The ReSTAGE Collaboration: defining optimal bleeding criteria for onset of early menopausal transition. Fertil Steril 2008;89:129-140.
22. Randolph JF, Jr., Zheng H, Sowers MR, et al. Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab 2011;96:746-754.
23. Vital signs: current cigarette smoking among adults aged >or=18 years - United States. MMWR Morb Mortal Wkly Rep 2009;59: 1135-1140.
24. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-241.
25. Merrill RM, Layman AB, Oderda G, Asche C. Risk estimates of hysterectomy and selected conditions commonly treated with hysterectomy. Ann Epidemiol 2008;18:253-260. (Pubitemid 351232240)
26. Freeman EW, Gracia CR, Sammel MD, Lin H, Lim LC, Strauss JF III. Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril 2007;87:101-106. (Pubitemid 46013875)
27. Gracia CR, Freeman EW, Sammel MD, Lin H, Nelson DB. The relationship between obesity and race on inhibin B during the menopause transition. Menopause 2005;12:559-566. (Pubitemid 41362080)
28. Huddleston HG, Cedars MI, Sohn SH, Giudice LC, Fujimoto VY. Racial and ethnic disparities in reproductive endocrinology and infertility. Am J Obstet Gynecol 2010;202:413-419.
29. Manson JM, Sammel MD, Freeman EW, Grisso JA. Racial differences in sex hormone levels in women approaching the transition to menopause. Fertil Steril 2001;75:297-304. (Pubitemid 32112105)
30. Randolph JF Jr, Sowers M, Bondarenko IV, Harlow SD, Luborsky JL, Little RJ. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab 2004;89:1555-1561. (Pubitemid 38507902)
31. Randolph JF Jr, Sowers M, Gold EB, et al. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab 2003;88:1516-1522. (Pubitemid 36623363)
32. Sammel MD, Freeman EW, Liu Z, Lin H, Guo W. Factors that influence entry into stages of the menopausal transition. Menopause 2009;16:1218-1227.
33. Su HI, Sammel MD, Freeman EW, Lin H, DeBlasis T, Gracia CR. Body size affects measures of ovarian reserve in late reproductive age women. Menopause 2008;15:857-861.
34. Sievert LL, Begum K, Sharmeen T, Chowdhury O, Muttukrishna S, Bentley G. Patterns of occurrence and concordance between subjective and objective hot flashes among Muslim and Hindu women in Sylhet, Bangladesh. Am J Hum Biol 2008;20:598-604.
35. Sievert LL, Saliba M, Reher D, et al. The medical management of menopause: a four-country comparison care in urban areas. Maturitas 2008;59:7-21.
36. Battistini M, Freeman EW, Grisso JA, Sammel M, Hollander L, Garcia-Espana B. Pilot study of racial differences and longitudinal changes in inhibin B in the late reproductive years. Fertil Steril 2002; 77:193-195. (Pubitemid 34093919)
37. Broekmans FJ, Faddy MJ, Scheffer G, te Velde ER. Antral follicle counts are related to age at natural fertility loss and age at menopause. Menopause 2004;11:607-614. (Pubitemid 40353223)
38. Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev 2009;30:465-493.
39. Burger HG, Hale GE, Dennerstein L, Robertson DM. Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause 2008;15:603-612.
40. Burger HG, Hale GE, Robertson DM, Dennerstein L. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update 2007;13:559-565. (Pubitemid 350018524)
41. Freeman EW, Sammel MD, Lin H, Gracia CR. Obesity and reproductive hormone levels in the transition to menopause. Menopause 2010;17:718-726.
42. Hale GE, Zhao X, Hughes CL, Burger HG, Robertson DM, Fraser IS. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system. J Clin Endocrinol Metab 2007;92:3060-3067. (Pubitemid 47236371)
43. Hansen KR, Hodnett GM, Knowlton N, Craig LB. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril 2011;95:170-175.
44. Hansen KR, Morris JL, Thyer AC, Soules MR. Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting. Fertil Steril 2003;80:577-583. (Pubitemid 37102869)
45. Klein NA, Houmard BS, Hansen KR, et al. Age-related analysis of inhibin A, inhibin B, and activin a relative to the intercycle monotropic follicle-stimulating hormone rise in normal ovulatory women. J Clin Endocrinol Metab 2004;89:2977-2981. (Pubitemid 38766396)
46. Knauff EA, Eijkemans MJ, Lambalk CB, et al. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab 2009;94:786-792.
47. La Marca A, Sighinolfi G, Radi D, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010;16:113-130.
48. Mulders AG, Laven JS, Eijkemans MJ, de Jong FH, Themmen AP, Fauser BC. Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reprod 2004;19:2036-2042. (Pubitemid 39236470)
49. O'Connor KA, Ferrell R, Brindle E, et al. Progesterone and ovulation across stages of the transition to menopause. Menopause 2009; 16:1178-1187.
50. O'Connor KA, Ferrell RJ, Brindle E, et al. Total and unopposed estrogen exposure across stages of the transition to menopause. Cancer Epidemiol Biomarkers Prev 2009;18:828-836.
51. Robertson DM. Anti-Mullerian hormone as a marker of ovarian reserve: an update. Womens Health (Lond Engl) 2008;4:137-141. (Pubitemid 351513633)
52. Robertson DM, Hale GE, Jolley D, Fraser IS, Hughes CL, Burger HG. Interrelationships between ovarian and pituitary hormones in ovulatory menstrual cycles across reproductive age. J Clin Endocrinol Metab 2009;94:138-144.
53. Sowers MR, Eyvazzadeh AD, McConnell D, et al. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 2008;93:3478-3483.
54. Sowers MR, Zheng H, McConnell D, Nan B, Harlow S, Randolph JF Jr. Follicle stimulating hormone and its rate of change in defining menopause transition stages. J Clin Endocrinol Metab 2008;93: 3958-3964.
55. Sowers MR, Zheng H, McConnell D, Nan B, Harlow SD, Randolph JF Jr. Estradiol rates of change in relation to the final menstrual period in a population-based cohort of women. J Clin Endocrinol Metab 2008;93:3847-3852.
56. Su HI, Sammel MD, Green J, et al. Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive- aged breast cancer survivors. Cancer 2010;116:592-599.
57. van Disseldorp J, Faddy MJ, Themmen AP, et al. Relationship of serum antimullerian hormone concentration to age at menopause. J Clin Endocrinol Metab 2008;93:2129-2134. (Pubitemid 351831526)
58. van Rooij IA, Broekmans FJ, Scheffer GJ, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 2005;83:979-987.
59. Ferrell RJ, Sowers M. Longitudinal, epidemiologic studies of female reproductive aging. Ann N Y Acad Sci 2010;1204:188-197.
60. Avis NE, Brockwell S, Randolph JF Jr., et al. Longitudinal changes in sexual functioning as women transition through menopause: results from the Study of Women's Health Across the Nation. Menopause 2009;16:442-452.
61. Avis NE, Zhao X, Johannes CB, Ory M, Brockwell S, Greendale GA. Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women's Health Across the Nation (SWAN). Menopause 2005;12:385-398. (Pubitemid 41098651)
62. Welt CK, McNicholl DJ, Taylor AE, Hall JE. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 1999;84:105-111. (Pubitemid 29036687)
63. Robertson DM, Hale GE, Fraser IS, Hughes CL, Burger HG. A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles. Menopause 2008;15:1139-1144.
64. Johannes CB, Crawford SL, Longcope C, McKinlay SM. Bleeding patterns and changes in the perimenopause: a longitudinal characterization of menstrual cycles. Clin Consult Obstet Gyncecol 1996;8:9-20. (Pubitemid 26088237)
65. Mitchell ES, Woods NF, Mariella A. Three stages of the menopausal transition from the Seattle Midlife Women's Health Study: toward a more precise definition. Menopause 2000;7:334-349.
66. Van Voorhis BJ, Santoro N, Harlow S, Crawford SL, Randolph J. The relationship of bleeding patterns to daily reproductive hormones in women approaching menopause. Obstet Gynecol 2008;112:101-108.
67. Roche Diagnostics. FSH, Follicle Stimulating Hormone. Package Insert: Elecsys and cobas analyzers. 2006-11, V 13. Roche Diagnostics, Indianapolis, IN
68. Abbott Laboratories. FSH. Package Insert: Architect Analyzers; 6C24, 34-4680/R1. 2007-10.
69. Stricker R, Eberhart R, Chevailler MC, Quinn FA, Bischof P. Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer. Clin Chem Lab Med 2006;44:883-887.
70. Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril 2001;76:456-460.
71. Stiles M, Redmer J, Paddock E, Schrager S. Gynecologic issues in geriatric women. J Womens Health (Larchmt) 2012;21:4-9.
72. Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med 2005;118:14-24.
73. Hall JE. Neuroendocrine physiology of the early and late menopause. Endocrinol Metab Clin North Am 2004;33:637-659. (Pubitemid 39388979)
74. Hall JE, Lavoie HB, Marsh EE, Martin KA. Decrease in gonadotropin- releasing hormone (GnRH) pulse frequency with aging in postmenopausal women. J Clin Endocrinol Metab 2000;85:1794-1800. (Pubitemid 32269278)
75. Schmitz KH, Lin H, Sammel MD, et al. Association of physical activity with reproductive hormones: the Penn Ovarian Aging Study. Cancer Epidemiol Biomarkers Prev 2007;16:2042-2047. (Pubitemid 47621178)
76. Bidet M, Bachelot A, Bissauge E, et al. Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. J Clin Endocrinol Metab 2011;96:3864-3872.
77. Johnson BD, Merz CN, Braunstein GD, et al. Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Womens Health (Larchmt) 2004;13:872-887. (Pubitemid 39545414)
78. Gelbaya TA, Nardo LG, Fitzgerald CT, Horne G, Brison DR, Lieberman BA. Ovarian response to gonadotropins after laparoscopic salpingectomy or the division of fallopian tubes for hydrosalpinges. Fertil Steril 2006;85:1464-1468.
79. Hehenkamp WJ, Volkers NA, Broekmans FJ, et al. Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum Reprod 2007;22:1996-2005. (Pubitemid 47062769)
80. Qu X, Cheng Z, Yang W, Xu L, Dai H, Hu L. Controlled clinical trial assessing the effect of laparoscopic uterine arterial occlusion on ovarian reserve. J Minim Invasive Gynecol 2010;17:47-52.
81. Sezik M, Ozkaya O, Demir F, Sezik HT, Kaya H. Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow. J Obstet Gynaecol Res 2007;33:863-869. (Pubitemid 350086521)
82. Dahlgren E, Johansson S, Lindstedt G, et al. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 1992;57:505-513 .
83. Elting MW, Korsen TJ, Rekers-Mombarg LT, Schoemaker J. Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum Reprod 2000;15:24-28.
84. Elting MW, Kwee J, Korsen TJ, Rekers-Mombarg LT, Schoemaker J. Aging women with polycystic ovary syndrome who achieve regular menstrual cycles have a smaller follicle cohort than those who continue to have irregular cycles. Fertil Steril 2003;79:1154-1160. (Pubitemid 36547854)
85. Santoro N, Arnsten JH, Buono D, Howard AA, Schoenbaum EE. Impact of street drug use, HIV infection, and highly active antiretroviral therapy on reproductive hormones in middle-aged women. J Womens Health (Larchmt) 2005;14:898-905. (Pubitemid 43137296)
86. Santoro N, Lo Y, Moskaleva G, et al. Factors affecting reproductive hormones in HIV-infected, substance-using middle-aged women. Menopause 2007;14:859-865. (Pubitemid 47517584)
87. Su HI, Alton J, Sherman L, Stankiewicz C, Ratcliffe S, DeMichele A. Relationships between clinical and biochemical predictors of chemotherapy related amenorrhea in premenopausal adjuvant breast cancer patients. American Society of Clinical Oncology Annual Meeting Proceedings, Part 12007. p. 11011
88. Su HI, Sammel MD, Velders L, et al. Association of cyclophosphamide drug-metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors. Fertil Steril 2009;94:645-654.
89. Sukumvanich P, Case LD, Van Zee K, et al. Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study. Cancer 2010;116:3102-3111.
90. Welt CK, Pagan YL, Smith PC, Rado KB, Hall JE. Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition. J Clin Endocrinol Metab 2003;88:1766-1771. (Pubitemid 36623402)